Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Soltis Investment Advisors LLC grew its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 742 shares of the biopharmaceutical company’s stock after purchasing an additional 47 shares during the period. Soltis […]
89% and 84% of patients were maintained on ≥12- and ≥16-week dosing intervals, respectively, throughout the two-year period, while sustaining their vision...
Ziegler Capital Management LLC trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,063 shares of the biopharmaceutical company’s stock after selling 132 shares during the […]
Achmea Investment Management B.V. trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 29.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,518 shares of the biopharmaceutical company’s stock after selling 6,204 shares during the quarter. Achmea Investment Management B.V.’s […]
First National Bank of Omaha lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.4% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,506 shares of the biopharmaceutical company’s stock after selling 254 shares during […]